Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers. (Q33753677)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers. |
scientific article |
Statements
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers (English)
Wenjia Qu
Jenny Z Song
Aaron L Statham
Kate I Patterson
Bruce Tabor
Toby Hulf
Susan M Henshall
Ruth Pe Benito
Anne-Maree Haynes
Regina Mayor
Robert L Sutherland
23 November 2010